On the recordApril 27, 2016
I ask unanimous consent that the Special Committee on Aging be authorized to meet during the session of the Senate on April 27, 2016, at 3:30 p.m., in room SH-216 of the Hart Senate Office Building, to conduct a hearing entitled ``Valeant Pharmaceuticals' Business Model: the Repercussions for Patients and the Health Care System.'' The PRESIDING OFFICER. Without objection, it is so ordered. ____________________





